LOXL2 and neoplasm: LOXL2 is a protease that modifies the ECM by promoting cross-linking of collagen fibers, is believed to play an important role in tumor progression and fibrosis, with the potential to inhibit tumor progression and reverse fibrosis (Figures 2, 3) (Muir et al., 2019; Sanyal et al., 2019).